NCT05002231 - Relative Bioavailability and Food Effect Study of Losmapimod 15 mg Tablets | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 19, 2021

Primary Completion Date

October 5, 2021

Study Completion Date

October 22, 2021

Conditions

Healthy Adult Subjects

Interventions

DRUG

Losmapimod 15 mg oral tablet

Subjects will receive one losmapimod 15 mg tablet by mouth under fasted conditions.

DRUG

Losmapimod two 7.5 mg oral tablets

Subjects will receive two losmapimod 7.5 mg tablets by mouth under fasted conditions.

DRUG

Losmapimod one 15 mg oral tablet

Subjects will receive one losmapimod 15 mg tablet by mouth under fed conditions.

Trial Locations (1)

PPD Phase I Clinic, Austin